Showing results (31-40 of 155) with videos related to
Sort By:
Pageof 16
Advances in Biochemical Psychopharmacology|January 1, 1983
Brain iron and dopamine receptor functionM B Youdim, D Ben-Shachar, R Ashkenazi, et al.Advances in Biochemical Psychopharmacology|January 1, 1980
Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholismA Carlsson, R Adolfsson, S M Aquilonius, et al.Advances in Biochemical Psychopharmacology|January 1, 1976
Octopamine as a putative neurotransmitterJ M Saavedra, J AxelrodAdvances in Biochemical Psychopharmacology|January 1, 1976
Long-term regulatory mechanisms for tyrosine hydroxylase in sympathetic ganglia and carotid bodyI HanbauerAdvances in Biochemical Psychopharmacology|January 1, 1988
Spinal cord cultured neurons: an in vitro model to study GABA synaptic pharmacologyM Ticku, A Mehta, P LehoullierAdvances in Biochemical Psychopharmacology|January 1, 1976
Changes of rat cerebellar guanosine 3',5'-cyclic phosphate by dopaminergic mechanisms in vivoW P Burkard, L Pieri, W HaefelyAdvances in Biochemical Psychopharmacology|January 1, 1976
Substance P and primary afferent transmissionM Otsuka, S Konishi, T Takahashi, et al.Advances in Biochemical Psychopharmacology|January 1, 1980
Dopamine and 5-HT supersensitivity in nonorganic central pain and in morphine abstinence: fortuitous or renal analogy?F Sicuteri, B Anselmi, P L Del BiancoAdvances in Biochemical Psychopharmacology|January 1, 1980
Evaluation of Parkinson's diseaseA Lieberman, M Dziatolowski, G Gopinathan, et al.Advances in Biochemical Psychopharmacology|January 1, 1980
Effects of chronic treatment with 1-sulpiride and haloperidol on central dopamine turnover evaluated in dopamine cell body and nerve terminal-rich areasL F Agnati, K Andersson, K Fuxe, et al.Pageof 16